The cuts largely affect Democratic-led states as the two parties fight over the shutdown of the federal government. By Brad Plumer and Maxine Joselow Reporting from Washington The Energy Department ...

The study, conducted by a research team in Denmark, included an analysis of 19 separate clinical trials that evaluated tramadol versus a placebo in treating various types of chronic pain. The trials ...

Wealth has long been tied to longevity in the U.S. and other countries, but a new analysis helps quantify the gap between how long low-income older Americans and their more affluent peers tend to live ...

The ocean hidden under the icy shell of Saturn's moon Enceladus harbors complex organic molecules, a study said Wednesday, offering further evidence that the small world could have all the right ...

WASHINGTON (AP) — Earth’s nastiest and costliest wildfires are blazing four times more often now than they did in the 1980s because of human-caused climate change and people moving closer to wildlands ...

People with certain bacteria and fungi in their mouths may face a dramatically higher risk of pancreatic cancer — more than three times greater — according to new research from NYU Langone Health and ...

The Trump administration is withholding some $18 billion from major infrastructure projects in New York City, citing concerns over diversity, equity, and inclusion (DEI). Office of Management and ...

The new research provides evidence that Covid reinfections can increase the risk of long-term health consequences. By Pam Belluck Pam Belluck has covered long Covid since the condition first emerged.

Central Texas drivers know one thing for sure: The roads are always under construction. From new lanes and flyovers to massive rebuilds, crews from the Texas Department of Transportation, the Central ...

Jessa Rogers receives funding from the Australian Research Council as a DECRA Fellow. She is the Managing Director of Baayi Consulting. The Early Childhood Report for Footprints in Time: The ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...